Financial News
SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Spectrum Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Los Angeles - (NewMediaWire) - October 20, 2021 - The Schall Law Firm, a national shareholder rights litigation
firm, reminds investors of a class action lawsuit against Spectrum
Pharmaceuticals, Inc. (“Spectrum” or “the Company”) (NASDAQ: SPPI) for violations of §§10(b) and 20(a) of the
Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the
U.S. Securities and Exchange Commission.
Investors who purchased the Company's securities
between December 27, 2018 and August 5, 2021, inclusive (the ''Class Period''),
are encouraged to contact the firm before November 1, 2021.
If you are a shareholder who suffered a loss, click here to participate.
We also encourage you to contact Brian Schall of
the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067,
at 310-301-3335, to discuss your rights free of charge. You can also reach us
through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.
The class, in this case, has not yet been
certified, and until certification occurs, you are not represented by an
attorney. If you choose to take no action, you can remain an absent class member.
According to the Complaint, the Company made
false and misleading statements to the market. Spectrum’s manufacturing
facility for ROLONTIS failed to maintain appropriate controls and procedures.
These deficiencies diminished the likelihood of the Company’s Biologics License
Application (BLA) for ROLONTIS receiving FDA approval. Based on these facts,
the Company’s public statements were false and materially misleading throughout
the class period. When the market learned the truth about Spectrum, investors
suffered damages.
Join the case to recover your losses.
The Schall Law Firm represents investors
around the world and specializes in securities class action lawsuits and
shareholder rights litigation.
This press release may be considered Attorney
Advertising in some jurisdictions under the applicable law and rules of ethics.
CONTACT:
The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
SOURCE:
The Schall Law Firm
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.